From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease (Q37837477)

24 August 2017

1 reference

title

From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease (English)

1 reference

24 August 2017

0 references

Alessandra Mortellaro

series ordinal

1

1 reference

24 August 2017

Paola Ricciardi-Castagnoli

series ordinal

2

1 reference

24 August 2017

publication date

8 February 2011

1 reference

Immunology & Cell Biology

24 August 2017

published in

1 reference

24 August 2017

volume

89

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

332-339

1 reference

An overview of the immune system

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The interface between innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Generating memory with vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Immunology: polarizing a T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

IL-17/Th17 in anti-fungal immunity: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Dendritic cells as sensors of environmental perturbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

NLR proteins: integral members of innate immunity and mediators of inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Direct gene transfer into mouse muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Genetic immunization is a simple method for eliciting an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Designing recombinant vaccines with viral properties: a rational approach to more effective vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Activation of HIV-1 Gag-specific CD8+ T cells by yeast-derived VLP-pulsed dendritic cells is influenced by the level of mannose on the VLP antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Molecular and cellular signatures of human vaccine adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The ABC of clinical and experimental adjuvants--a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The global impact of vaccines containing aluminium adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Towards an understanding of the adjuvant action of aluminium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Cell death induced by vaccine adjuvants containing surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The inflammatory response to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Molecular identification of a danger signal that alerts the immune system to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The endogenous danger signal, crystalline uric acid, signals for enhanced antibody immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Antituberculous vaccine development: a perspective for the endemic world

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Immunological responses and protective immunity against tuberculosis conferred by vaccination of Balb/C mice with the attenuated Mycobacterium tuberculosis (phoP) SO2 strain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Expression switching in the stevor and Pfmc-2TM superfamilies in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

PfEMP1: an antigen that plays a key role in the pathogenicity and immune evasion of the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Diverse expression patterns of subgroups of the rif multigene family during Plasmodium falciparum gametocytogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Protective Immunity produced by the Injection of X-irradiated Sporozoites of Plasmodium berghei

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Protection against malaria induced by irradiated sporozoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Protection against a malaria challenge by sporozoite inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Deviation of the B cell pathway in senescent mice is associated with reduced surrogate light chain expression and altered immature B cell generation, phenotype, and light chain expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Proinflammatory adjuvants enhance the cognate helper activity of aged CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Influenza vaccination: policy versus evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Genetic susceptibility to infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Aspects of genetic susceptibility to human infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

A comparative review of HLA associations with hepatitis B and C viral infections across global populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Host Genetic Factors and Vaccine-Induced Immunity to HBV Infection: Haplotype Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

New genetic associations detected in a host response study to hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Has BCG attenuated to impotence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

Activation of dendritic cells and induction of CD4(+) T cell differentiation by aluminum-containing adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

CpG DNA is an effective oral adjuvant to protein antigens in mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Monophosphoryl lipid A activates both human dendritic cells and T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Immunization of man against sporozite-induced falciparum malaria

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Serum antibody responses after intradermal vaccination against influenza

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Immune response of neonates to oral poliomyelitis vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Genetic prediction of nonresponse to hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.152

7 January 2021

Identifiers

DOI

10.1038/ICB.2010.152

1 reference

Dimensions Publication ID

24 August 2017

1032143863

0 references

1 reference